Our Vision in Immuno-Oncology
Transform the lives of patients with cancer by pushing the boundaries of scientific research through a broad portfolio of investigational molecules and strategic collaborations.
Therapeutic approaches are being developed to inhibit tumor immunosuppression and drive antitumor T-cell immunity.
By leveraging the combination potential of our extensive portfolio we strive to redefine paradigms with the goal of developing personalized and life-changing cancer treatments.
At AstraZeneca and MedImmune, we follow the science and put patients first. We are dedicated to discovering approaches that enhance the immune system’s ability to fight cancer.